XBKK
THG
Market cap222mUSD
Nov 12, Last price
7.85THB
Name
Thonburi Healthcare Group PCL
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Thonburi Healthcare Group Public Company Limited, together with its subsidiaries, operates private hospitals in Thailand. The company operates through three segments: Medical Services Business, Healthcare Solution Provider, and Other Business. It offers services in various medical fields, including brain and neurology, bone and joint, gastro intestinal and liver, heart, and obstetrics and gynecology; and management services for provincial state hospitals, as well as for heart centers in the public and private sectors. The company also offers senior care and senior living, and home healthcare services; operates the patient rehabilitation center; conducts housing business for elderly; and operates care center and elderly carecenter, as well as distributes dental supplies brands, such as Adec, W&H, AO, Heraeus, Ivoclar, Megagen, SAM, Melag, and Alpro. It also sells pharmaceutical and medical goods in specialised stores; develops hospital management software; and develops land and property. The company operates four Bangkok-based hospitals, such as Thonburi, Thonburi 2, Thonburi Bamrungmuang hospitals, and Thonburi Burana Hospital, Pathum Thani; and four provincial hospitals, including Rajyindee, Ubonrak Thonburi, Sirivej Chanthaburi, and Thonburi Thungsong hospitals, as well as one hospital in the Republic of the Union of Myanmar. Thonburi Healthcare Group Public Company Limited was founded in 1976 and is headquartered in Bangkok, Thailand.
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||